For more than 20 years, Illumina has aspired to improve human health by unlocking the power of the genome. Our initial products enabled researchers to explore DNA in an entirely new way. Now, with more than 3400 patents worldwide and our sequencing-by-synthesis technologybeing used to generate over 90% of the world’s sequencing data, we are leading the way, one genomic breakthrough at a time. While the rate of progress continues to accelerate exponentially as we move towards precision medicine, we have only just begun to discover the true impact of genomics in areas we touch, including oncology, reproductive health, genetic disease, agriculture, microbiology, and beyond. This realization, and the discoveries we know lie ahead, are what inspire us to push the boundaries of our imagination and drive innovation.